User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease

  1. Peyrin–Biroulet Laurent, Deltenre Pierre, de Suray Nicolas, Branche Julien, Sandborn William J., Colombel Jean–Frédéric, Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials, 10.1016/j.cgh.2008.03.014
  2. Mahadevan, Gastroenterology, 128, A322 (2005)
  3. Cornish J, Tan E, Teare J, Teoh T G, Rai R, Clark S K, Tekkis P P, A meta-analysis on the influence of inflammatory bowel disease on pregnancy, 10.1136/gut.2006.108324
  4. Mahadevan Uma, Sandborn William J., Li De–Kun, Hakimian Shahbaz, Kane Sunanda, Corley Douglas A., Pregnancy Outcomes in Women With Inflammatory Bowel Disease: A Large Community-Based Study From Northern California, 10.1053/j.gastro.2007.07.019
  5. Nguyen Geoffrey C., Boudreau Heather, Harris Mary L., Maxwell Cynthia V., Outcomes of Obstetric Hospitalizations Among Women With Inflammatory Bowel Disease in the United States, 10.1016/j.cgh.2008.10.022
  6. Dominitz, Am J Gastroenterol, 96, 635 (2001)
  7. Kornfeld Dan, Cnattingius Sven, Ekbom Anders, Pregnancy outcomes in women with inflammatory bowel disease—A population-based cohort study, 10.1016/s0002-9378(97)70298-9
  8. Baird Donna Day, Narendranathan M., Sandler Robert S., Increased risk of preterm birth for women with inflammatory bowel disease, 10.1016/0016-5085(90)90617-a
  9. Simister N, Placental transport of immunoglobulin G, 10.1016/s0264-410x(03)00334-7
  10. van der Woude C. Janneke, Kolacek Sanja, Dotan Iris, Øresland Tom, Vermeire Séverine, Munkholm Pia, Mahadevan Uma, Mackillop Lucy, Dignass Axel, European evidenced-based consensus on reproduction in inflammatory bowel disease, 10.1016/j.crohns.2010.07.004
  11. Mahadevan Uma, Cucchiara Salvatore, Hyams Jeffrey S, Steinwurz Flavio, Nuti F, Travis Simon P L, Sandborn William J, Colombel Jean-Frederio, The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics, 10.1038/ajg.2010.464
  12. Zelinkova Z., de Haar C., de Ridder L., Pierik M. J., Kuipers E. J., Peppelenbosch M. P., van der Woude C. J., High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy : Intra-uterine exposure to infliximab, 10.1111/j.1365-2036.2011.04617.x
  13. Vasiliauskas Eric A., Church Joseph A., Silverman Neil, Barry Mary, Targan Stephan R., Dubinsky Marla C., Case Report: Evidence for Transplacental Transfer of Maternally Administered Infliximab to the Newborn, 10.1016/j.cgh.2006.07.018
  14. Mahadevan Uma, Wolf Douglas C., Dubinsky Marla, Cortot Antoine, Lee Scott D., Siegel Corey A., Ullman Thomas, Glover Sarah, Valentine John F., Rubin David T., Miller Jocelyn, Abreu Maria T., Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease, 10.1016/j.cgh.2012.11.011
  15. Ternant David, Mulleman Denis, Degenne Danielle, Willot St??phanie, Guillaumin Jean-Maurice, Watier Herv??, Goupille Philippe, Paintaud Gilles, An Enzyme-Linked Immunosorbent Assay for Therapeutic Drug Monitoring of Infliximab : , 10.1097/01.ftd.0000189901.08684.4b
  16. Mahadevan, Gastroenterology, 136 (2009)
  17. Lichtenstein, Gastroenterology, 126, A54 (2004)
  18. Katz Jeffry A., Antoni Christian, Keenan Gregory F., Smith Deirdre E., Jacobs Stephen J., Lichtenstein Gary R., Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid Arthritis, 10.1111/j.1572-0241.2004.30186.x
  19. Schnitzler Fabian, Fidder Herma, Ferrante Marc, Ballet Vera, Noman Maja, Van Assche Gert, Spitz Bernard, Hoffman Ilse, Van Steen Kristel, Vermeire Séverine, Rutgeerts Paul, Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy : , 10.1002/ibd.21583
  20. Johnson Diana L., Jones Kenneth L., Chambers Christina D., Salas Elizabeth, 142 Pregnancy Outcomes in Women Exposed to Adalimumab: the OTIS Autoimmune Diseases in Pregnancy Project, 10.1016/s0016-5085(09)60125-6
  21. Casanova M J, Chaparro M, Domènech E, Barreiro-de Acosta M, Bermejo F, Iglesias E, Gomollón F, Rodrigo L, Calvet X, Esteve M, García-Planella E, García-López S, Taxonera C, Calvo M, López M, Ginard D, Gómez-García M, Garrido E, Pérez-Calle J L, Beltrán B, Piqueras M, Saro C, Botella B, Dueñas C, Ponferrada A, Mañosa M, García-Sánchez V, Maté J, Gisbert J P, Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease, 10.1038/ajg.2012.430
  22. Nielsen Ole Haagen, Loftus Jr Edward V, Jess Tine, Safety of TNF-α inhibitors during IBD pregnancy: a systematic review, 10.1186/1741-7015-11-174
  23. Mahadevan Uma, Martin Christopher F., Sandler Robert S., Kane Sunanda V., Dubinsky Marla, Lewis James D., Sandborn William J., Sands Bruce E., 865 PIANO: A 1000 Patient Prospective Registry of Pregnancy Outcomes in Women With IBD Exposed to Immunomodulators and Biologic Therapy, 10.1016/s0016-5085(12)60561-7
  24. Coelho J., Beaugerie L., Colombel J. F., Hebuterne X., Lerebours E., Lemann M., Baumer P., Cosnes J., Bourreille A., Gendre J. P., Seksik P., Blain A., Metman E. H., Nisard A., Cadiot G., Veyrac M., Coffin B., Dray X., Carrat F., Marteau P., , Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study, 10.1136/gut.2010.222893
  25. Satsangi J, The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, 10.1136/gut.2005.082909
  26. World Health Organization International statistical classification of diseases and related health problems http://apps.who.int/classifications/icd10/browse/2010/en.
  27. Nørgård Bente, Hundborg Heidi H., Jacobsen Bent A., Nielsen Gunnar L, Fonager Kirsten, Disease Activity in Pregnant Women With Crohn's Disease and Birth Outcomes: A Regional Danish Cohort Study, 10.1111/j.1572-0241.2007.01355.x
  28. Nielsen O. H., Andreasson B., Bondesen S., Jarnum S., Pregnancy in Ulcerative Colitis, 10.3109/00365528309182088
  29. Fonager Kirsten, Sorensen Henrik Toft, Olsen Jorn, Dahlerup Jens Frederik, Rasmussen Sten Norby, Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries, 10.1111/j.1572-0241.1998.00698.x
  30. Bortoli A., Pedersen N., Duricova D., D′Inca R., Gionchetti P., Panelli M. R., Ardizzone S., Sanroman A. L., Gisbert J. P., Arena I., Riegler G., Marrollo M., Valpiani D., Corbellini A., Segato S., Castiglione F., Munkholm P., , Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006 : Pregnancy outcome in IBD, 10.1111/j.1365-2036.2011.04794.x
  31. Van Assche Gert, Dignass Axel, Reinisch Walter, van der Woude C. Janneke, Sturm Andreas, De Vos Martine, Guslandi Mario, Oldenburg Bas, Dotan Iris, Marteau Philippe, Ardizzone Alessandro, Baumgart Daniel C., D'Haens Geert, Gionchetti Paolo, Portela Francisco, Vucelic Boris, Söderholm Johan, Escher Johanna, Koletzko Sibylle, Kolho Kaija-Leena, Lukas Milan, Mottet Christian, Tilg Herbert, Vermeire Séverine, Carbonnel Frank, Cole Andrew, Novacek Gottfried, Reinshagen Max, Tsianos Epameinondas, Herrlinger Klaus, Oldenburg Bas, Bouhnik Yoram, Kiesslich Ralf, Stange Eduard, Travis Simon, Lindsay James, The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations, 10.1016/j.crohns.2009.09.009
  32. Van Assche Gert, Dignass Axel, Bokemeyer Bernd, Danese Silvio, Gionchetti Paolo, Moser Gabriele, Beaugerie Laurent, Gomollón Fernando, Häuser Winfried, Herrlinger Klaus, Oldenburg Bas, Panes Julian, Portela Francisco, Rogler Gerhard, Stein Jürgen, Tilg Herbert, Travis Simon, Lindsay James O., Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations, 10.1016/j.crohns.2012.09.005
  33. Mahadevan U, Fertility and pregnancy in the patient with inflammatory bowel disease, 10.1136/gut.2005.078097
  34. Delcroix Michel, , 10.1016/s0368-2315(05)82966-7
  35. Jürgens Matthias, Brand Stephan, Filik Levent, Hübener Christoph, Hasbargen Uwe, Beigel Florian, Tillack Cornelia, Göke Burkhard, Ochsenkühn Thomas, Seiderer Julia, Safety of Adalimumab in Crohnʼs Disease During Pregnancy: Case Report and Review of the Literature : , 10.1002/ibd.21198
  36. Oussalah A, Bigard M-A, Peyrin-Biroulet L, Certolizumab use in pregnancy, 10.1136/gut.2008.166884
  37. Zelinkova Zuzana, van der Ent Cokkie, Bruin Karlien F., van Baalen Onno, Vermeulen Hestia G., Smalbraak Herman J.T., Ouwendijk Rob J., Hoek Aad C., van der Werf Sjoerd D., Kuipers Ernst J., van der Woude C. Janneke, Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure, 10.1016/j.cgh.2012.10.024
Bibliographic reference Seirafi, M. ; De Vroey, B. ; Amiot, A. ; Seksik, P. ; Roblin, X. ; et. al. Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease. In: Alimentary Pharmacology and Therapeutics, Vol. 40, no. 4, p. 363-373 (2014)
Permanent URL http://hdl.handle.net/2078.1/158331